protosappanin a has been researched along with isoliquiritigenin in 1 studies
| Studies (protosappanin a) | Trials (protosappanin a) | Recent Studies (post-2010) (protosappanin a) | Studies (isoliquiritigenin) | Trials (isoliquiritigenin) | Recent Studies (post-2010) (isoliquiritigenin) |
|---|---|---|---|---|---|
| 22 | 0 | 14 | 472 | 2 | 324 |
| Protein | Taxonomy | protosappanin a (IC50) | isoliquiritigenin (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 1.87 | |
| Interstitial collagenase | Homo sapiens (human) | 0.016 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.269 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 0.01 | |
| Stromelysin-1 | Homo sapiens (human) | 0.081 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.269 | |
| Matrilysin | Homo sapiens (human) | 0.008 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.269 | |
| Aromatase | Homo sapiens (human) | 3.8 | |
| 17-beta-hydroxysteroid dehydrogenase type 1 | Homo sapiens (human) | 2.83 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.01 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 0.32 | |
| Proteasome subunit beta type-5 | Homo sapiens (human) | 4.88 | |
| 17-beta-hydroxysteroid dehydrogenase type 2 | Homo sapiens (human) | 0.36 | |
| Collagenase 3 | Homo sapiens (human) | 0.014 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.269 | |
| NACHT, LRR and PYD domains-containing protein 3 | Homo sapiens (human) | 1.54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, J; Geng, MY; Jiang, H; Ke, CQ; Li, HL; Lin, LG; Lin, LP; Liu, QF; Tang, CP; Tong, LJ; Xie, H; Ye, Y; Zhao, WM | 1 |
1 other study(ies) available for protosappanin a and isoliquiritigenin
| Article | Year |
|---|---|
Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening.
Topics: Adenosine Triphosphate; Cell Line, Tumor; Cell-Free System; Drug Evaluation, Preclinical; Enzyme-Linked Immunosorbent Assay; Fabaceae; Flavonoids; Hematoxylin; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Phosphorylation; Protein Kinase Inhibitors; Signal Transduction; src-Family Kinases; Structure-Activity Relationship | 2008 |